Does DOTS work in populations with drug-resistant tuberculosis? (Q53861882)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Does DOTS work in populations with drug-resistant tuberculosis? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

Miriam Bobadilla-Del Valle

10 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Alfredo Ponce-de-Leon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Jose Sifuentes-Osornio

7

object named as

José Sifuentes-Osornio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Areli Martínez-Gamboa

5

object named as

Areli Martínez-Gamboa

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Lourdes García-García

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Manuel Palacios-Martínez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Peter M Small

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

English

0 references

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

9466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

1239-1245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15811457%20AND%20SRC:MED&resulttype=core&format=json

Tuberculosis drug resistance: a global threat

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

Tuberculosis epidemiology and control in Veracruz, Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

Methodological problems in the molecular epidemiology of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

Effect of drug resistance on the generation of secondary cases of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

Changes in the transmission of tuberculosis in New York City from 1990 to 1999

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

Scale up: meeting targets in global tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

The standard of care debate: the Declaration of Helsinki versus the international consensus opinion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021

The ancillary-care responsibilities of medical researchers. An ethical framework for thinking about the clinical care that researchers owe their subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2974812-1

7 January 2021